LATEST UPDATES

IVIEW Therapeutics to Present Cutting-Edge Ocular Research at ARVO 2025 in Salt Lake City

IVIEW Therapeutics Announces Topline Results from Phase 1/2 Trial of IVW-1001 Ophthalmic Eyelid Wipe for Dry Eye Disease

Copyright © 2025 iVIEW Therapeutics, Inc. All rights reserved.

Terms of Use

Privacy Policy